| Year |
Citation |
Score |
| 2019 |
Liu ZB, Ezzedine NE, Eterovic AK, Ensor JE, Huang HJ, Albanell J, Choi DS, Lluch A, Liu Y, Rojo F, Wong H, Martínez-Dueñas E, Guerrero-Zotano Á, Shao ZM, Darcourt JG, ... ... Dave B, et al. Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases. Breast Cancer Research and Treatment. PMID 31388936 DOI: 10.1007/S10549-019-05374-X |
0.426 |
|
| 2019 |
Liu D, Dave B. Abstract 3441: A RPL39-SGK3 signaling pathway that may play a key role in breast cancer therapy resistance Cancer Research. 79: 3441-3441. DOI: 10.1158/1538-7445.Sabcs18-3441 |
0.454 |
|
| 2018 |
Rosato RR, Dávila-González D, Choi DS, Qian W, Chen W, Kozielski AJ, Wong H, Dave B, Chang JC. Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models. Breast Cancer Research : Bcr. 20: 108. PMID 30185216 DOI: 10.1186/S13058-018-1037-4 |
0.429 |
|
| 2018 |
Dávila-González D, Choi DS, Rosato RR, Granados-Principal S, Kuhn JG, Li WF, Qian W, Chen W, Kozielski AJ, Wong HH, Dave B, Chang JC. Pharmacological inhibition of NOS activates ASK1/JNK pathway augmenting docetaxel-mediated apoptosis in triple negative breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29301832 DOI: 10.1158/1078-0432.Ccr-17-1437 |
0.423 |
|
| 2018 |
Davila-Gonzalez D, Rosato RR, Dave B, Choi DS, Qian W, Kozielski AJ, Chen W, Ensor JE, Chang JC. Abstract A202: Evaluating the combination of anti-PD-1 and nitric oxide synthase inhibition therapy in 12 triple-negative breast cancer patient-derived xenografts using a human-derived immune system model Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-A202 |
0.383 |
|
| 2017 |
Liu Y, Choi DS, Sheng J, Ensor JE, Liang DH, Rodriguez-Aguayo C, Polley A, Benz S, Elemento O, Verma A, Cong Y, Wong H, Qian W, Li Z, Granados-Principal S, ... ... Dave B, et al. HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 Pathway. Stem Cell Reports. PMID 29249663 DOI: 10.1016/J.Stemcr.2017.11.010 |
0.473 |
|
| 2017 |
Pence KA, Mishra DK, Thrall M, Dave B, Kim MP. Breast cancer cells form primary tumors on ex vivo four-dimensional lung model. The Journal of Surgical Research. 210: 181-187. PMID 28457326 DOI: 10.1016/J.Jss.2016.11.019 |
0.41 |
|
| 2017 |
Dave B, Gonzalez DD, Liu ZB, Li X, Wong H, Granados S, Ezzedine NE, Sieglaff DH, Ensor JE, Miller KD, Radovich M, KarinaEtrovic A, Gross SS, Elemento O, Mills GB, et al. Role of RPL39 in Metaplastic Breast Cancer. Journal of the National Cancer Institute. 109. PMID 28040796 DOI: 10.1093/Jnci/Djw292 |
0.432 |
|
| 2017 |
Davila-Gonzalez D, Rosato RR, Qian W, Kozielski AJ, Chen W, Choi DS, Dave B, Kranjac D, Ensor JE, Chang JC. Abstract LB-196: Evaluation of anti PD-1 plus nitric oxide synthase inhibition combination therapy in 12 triple-negative breast cancer patient-derived xenografts using a human-derived immune system model Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-196 |
0.383 |
|
| 2016 |
Phan AT, Dave B. The pivotal role of mammalian target of rapamycin inhibition in the treatment of patients with neuroendocrine tumors. Cancer Medicine. PMID 27539383 DOI: 10.1002/Cam4.742 |
0.313 |
|
| 2016 |
Norvaisas P, Chan D, Yokoi K, Dave B, Ziemys A. The protein kinase promiscuities in the cancer-preventive mechanisms of NSAIDs. European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (Ecp). 25: 77-84. PMID 25714784 DOI: 10.1097/Cej.0000000000000129 |
0.354 |
|
| 2016 |
Teegavarapu PS, Dave B, Phan AT. Scientific rationale for revisiting targeting mTOR pathway in gastric cancer. Journal of Clinical Oncology. 34: e15558-e15558. DOI: 10.1200/Jco.2016.34.15_Suppl.E15558 |
0.317 |
|
| 2016 |
Dave B, Choi DS, Wong H, Liu Y, Gunamalai PS, Chang JC. Abstract B53: The role of RPL39 induced autophagy in resistance of breast cancer stem cells Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Metca15-B53 |
0.438 |
|
| 2016 |
Mujoo K, Pandita RK, Tiwari A, Charaka V, Hittelman WN, Hegde M, Wang H, Hunt CR, Dave B, Chang J, Butler EB, Pandita TK. Abstract 518: Ionizing radiation-induced DNA damage response decreases during induced pluripotent and embryonic stem cell differentiation Cancer Research. 76: 518-518. DOI: 10.1158/1538-7445.Am2016-518 |
0.333 |
|
| 2015 |
Liang DH, El-Zein R, Dave B. Autophagy Inhibition to Increase Radiosensitization in Breast Cancer. Journal of Nuclear Medicine & Radiation Therapy. 6. PMID 26613064 DOI: 10.4172/2155-9619.1000254 |
0.446 |
|
| 2015 |
Young CD, Zimmerman LJ, Hoshino D, Formisano L, Hanker AB, Gatza ML, Morrison MM, Moore PD, Whitwell CA, Dave B, Stricker T, Bhola NE, Silva GO, Patel P, Brantley-Sieders DM, et al. Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer. Molecular & Cellular Proteomics : McP. 14: 1959-76. PMID 25953087 DOI: 10.1074/Mcp.M115.049783 |
0.368 |
|
| 2015 |
Granados-Principal S, Liu Y, Guevara ML, Blanco E, Choi DS, Qian W, Patel T, Rodriguez AA, Cusimano J, Weiss HL, Zhao H, Landis MD, Dave B, Gross SS, Chang JC. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer. Breast Cancer Research : Bcr. 17: 25. PMID 25849745 DOI: 10.1186/S13058-015-0527-X |
0.456 |
|
| 2015 |
Bharadwaj U, Eckols TK, Kolosov M, Kasembeli MM, Adam A, Torres D, Zhang X, Dobrolecki LE, Wei W, Lewis MT, Dave B, Chang JC, Landis MD, Creighton CJ, Mancini MA, et al. Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer. Oncogene. 34: 1341-53. PMID 24681959 DOI: 10.1038/Onc.2014.72 |
0.469 |
|
| 2015 |
Dave B, Phan A. Abstract 2539: Targeting therapy-resistant gastric and esophageal cancers with mTOR ATP site inhibitors Cancer Research. 75: 2539-2539. DOI: 10.1158/1538-7445.Am2015-2539 |
0.313 |
|
| 2015 |
Liu Y, Choi DS, Grandos-Principal S, Qian W, Burey L, Wong H, Rodriguez-Aguayo C, Sood A, Li Z, Wong S, Weiss H, Dave B, Landis M, Chang JC. Abstract 2312: Identifying novel cancer stem cell target for triple-negative breast cancer Cancer Research. 75: 2312-2312. DOI: 10.1158/1538-7445.Am2015-2312 |
0.479 |
|
| 2015 |
Dave B, Chang J. Abstract 2248: Mechanism of action of RPL39 in breast cancer initiation and metastasis Cancer Research. 75: 2248-2248. DOI: 10.1158/1538-7445.Am2015-2248 |
0.408 |
|
| 2015 |
Choi DS, Yi L, Rodriguez-Aguayo C, Dave B, Wong STC, Sood AK, Chang JC. Abstract LB-C09: Hematological and Neurological Expressed 1-Like (HN1L) is a Novel Therapeutic Target for Triple Negative Breast Cancer Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-Lb-C09 |
0.464 |
|
| 2014 |
Patel TA, Dave B, Rodriguez AA, Chang JC, Perez EA, Colon-Otero G. Dual HER2 blockade: preclinical and clinical data. Breast Cancer Research : Bcr. 16: 419. PMID 25928889 DOI: 10.1186/S13058-014-0419-5 |
0.382 |
|
| 2014 |
Patel TA, Dave B, Rodriguez AA, Chang JC, Perez EA, Colon-Otero G. Erratum: Dual HER2 blockade: preclinical and clinical data. Breast Cancer Research : Bcr. 16: 468. PMID 25927825 DOI: 10.1186/S13058-014-0468-9 |
0.337 |
|
| 2014 |
Jaganathan H, Gage J, Leonard F, Srinivasan S, Souza GR, Dave B, Godin B. Three-dimensional in vitro co-culture model of breast tumor using magnetic levitation. Scientific Reports. 4: 6468. PMID 25270048 DOI: 10.1038/Srep06468 |
0.378 |
|
| 2014 |
Dave B, Granados-Principal S, Zhu R, Benz S, Rabizadeh S, Soon-Shiong P, Yu KD, Shao Z, Li X, Gilcrease M, Lai Z, Chen Y, Huang TH, Shen H, Liu X, et al. Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling. Proceedings of the National Academy of Sciences of the United States of America. 111: 8838-43. PMID 24876273 DOI: 10.1073/Pnas.1320769111 |
0.437 |
|
| 2014 |
Choi DS, Blanco E, Kim YS, Rodriguez AA, Zhao H, Huang TH, Chen CL, Jin G, Landis MD, Burey LA, Qian W, Granados SM, Dave B, Wong HH, Ferrari M, et al. Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1. Stem Cells (Dayton, Ohio). 32: 2309-23. PMID 24809620 DOI: 10.1002/Stem.1746 |
0.397 |
|
| 2014 |
Jaganathan H, Mitra S, Srinivasan S, Dave B, Godin B. Design and in vitro evaluation of layer by layer siRNA nanovectors targeting breast tumor initiating cells. Plos One. 9: e91986. PMID 24694753 DOI: 10.1371/Journal.Pone.0091986 |
0.413 |
|
| 2014 |
Granados SM, Liu Y, Dave B, Landis MD, Gross SS, Chang JC. Abstract 4024: iNOS inhibition increases survival in triple negative breast cancer by targeting metastasis and epithelial-mesenchymal transition Cancer Research. 74: 4024-4024. DOI: 10.1158/1538-7445.Am2014-4024 |
0.45 |
|
| 2013 |
Chakrabarty A, Bhola NE, Sutton C, Ghosh R, Kuba MG, Dave B, Chang JC, Arteaga CL. Trastuzumab-resistant cells rely on a HER2-PI3K-FoxO-survivin axis and are sensitive to PI3K inhibitors. Cancer Research. 73: 1190-200. PMID 23204226 DOI: 10.1158/0008-5472.Can-12-2440 |
0.437 |
|
| 2013 |
Pabona JM, Dave B, Su Y, Montales MT, de Lumen BO, de Mejia EG, Rahal OM, Simmen RC. The soybean peptide lunasin promotes apoptosis of mammary epithelial cells via induction of tumor suppressor PTEN: similarities and distinct actions from soy isoflavone genistein. Genes & Nutrition. 8: 79-90. PMID 22864686 DOI: 10.1007/S12263-012-0307-5 |
0.407 |
|
| 2013 |
Dave B, Mitra S. Abstract 3768: Autophagy: a mechanism of resistance to therapy in breast cancer. Cancer Research. 73: 3768-3768. DOI: 10.1158/1538-7445.Am2013-3768 |
0.438 |
|
| 2013 |
Dave B, Granados S, Mai J, Choi DS, Gao DC, Mitra S, Shen H, Muthuswamy S, Mittal V, Ferrari M, Chang J. Abstract 2712: Identification of tumor initiating genes RPL39 and MLF2 that mediate lung metastasis through nitric oxide signaling and mesenchymal to epithelial transition. Cancer Research. 73: 2712-2712. DOI: 10.1158/1538-7445.Am2013-2712 |
0.459 |
|
| 2013 |
Choi DS, Blanco E, Granados-Principal SM, Dave B, Landis M, Wong H, Chang J. Abstract 237: Chloroquine inhibits cancer stem cells in triple negative breast cancer via regulation of DNA methylation. Cancer Research. 73: 237-237. DOI: 10.1158/1538-7445.Am2013-237 |
0.456 |
|
| 2013 |
Chang JC, Dave B, Granados-Principal S, Mai J, Gross S, Shen H, Mittal V, Ferrari M. Abstract CN06-02: Breast cancer stem cells. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-Cn06-02 |
0.481 |
|
| 2012 |
Dave B, Landis MD, Tweardy DJ, Chang JC, Dobrolecki LE, Wu MF, Zhang X, Westbrook TF, Hilsenbeck SG, Liu D, Lewis MT. Selective small molecule Stat3 inhibitor reduces breast cancer tumor-initiating cells and improves recurrence free survival in a human-xenograft model. Plos One. 7: e30207. PMID 22879872 DOI: 10.1371/Journal.Pone.0030207 |
0.45 |
|
| 2012 |
Dave B, Mittal V, Tan NM, Chang JC. Epithelial-mesenchymal transition, cancer stem cells and treatment resistance. Breast Cancer Research : Bcr. 14: 202. PMID 22264257 DOI: 10.1186/Bcr2938 |
0.425 |
|
| 2012 |
Creighton CJ, Sada YH, Zhang Y, Tsimelzon A, Wong H, Dave B, Landis MD, Bear HD, Rodriguez A, Chang JC. A gene transcription signature of obesity in breast cancer. Breast Cancer Research and Treatment. 132: 993-1000. PMID 21750966 DOI: 10.1007/S10549-011-1595-Y |
0.35 |
|
| 2012 |
Jaganathan H, Mitra S, Dave B, Godin B. Abstract P6-02-07: In vitro 3D Model of Breast Tumor Stroma Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P6-02-07 |
0.353 |
|
| 2012 |
Dave B, Granados S, Mitra S, Chang J. Abstract P5-03-12: Targeting breast cancer stem cells using the autopahgy inhibitor N-Acetyl cysteine Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P5-03-12 |
0.464 |
|
| 2011 |
Rexer BN, Ham AJ, Rinehart C, Hill S, Granja-Ingram Nde M, González-Angulo AM, Mills GB, Dave B, Chang JC, Liebler DC, Arteaga CL. Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition. Oncogene. 30: 4163-74. PMID 21499296 DOI: 10.1038/Onc.2011.130 |
0.391 |
|
| 2011 |
Garrett JT, Olivares MG, Rinehart C, Granja-Ingram ND, Sánchez V, Chakrabarty A, Dave B, Cook RS, Pao W, McKinely E, Manning HC, Chang J, Arteaga CL. Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase. Proceedings of the National Academy of Sciences of the United States of America. 108: 5021-6. PMID 21385943 DOI: 10.1073/Pnas.1016140108 |
0.385 |
|
| 2011 |
Dave B, Migliaccio I, Gutierrez MC, Wu MF, Chamness GC, Wong H, Narasanna A, Chakrabarty A, Hilsenbeck SG, Huang J, Rimawi M, Schiff R, Arteaga C, Osborne CK, Chang JC. Loss of phosphatase and tensin homolog or phosphoinositol-3 kinase activation and response to trastuzumab or lapatinib in human epidermal growth factor receptor 2-overexpressing locally advanced breast cancers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 166-73. PMID 21135276 DOI: 10.1200/Jco.2009.27.7814 |
0.375 |
|
| 2011 |
Dave B, Zhao H, Vahdat LT, Chang JC, Wong ST. Abstract LB-110: Bioinformatic discovery of repositioned drugs to target breast tumor initiating cells Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-110 |
0.407 |
|
| 2011 |
Garrett J, Rinehart C, Chakrabarty A, Dave B, Pao W, Manning C, Chang J, Arteaga C. Abstract 231: Upregulation of HER3 (ErbB3) levels and function counteracts the antitumor effect of HER2 and PI3K inhibitors Cancer Research. 71: 231-231. DOI: 10.1158/1538-7445.Am2011-231 |
0.419 |
|
| 2010 |
Dave B, Wynne R, Su Y, Korourian S, Chang JC, Simmen RC. Enhanced mammary progesterone receptor-A isoform activity in the promotion of mammary tumor progression by dietary soy in rats. Nutrition and Cancer. 62: 774-82. PMID 20661826 DOI: 10.1080/01635581.2010.494334 |
0.358 |
|
| 2010 |
Rodriguez AA, Makris A, Wu MF, Rimawi M, Froehlich A, Dave B, Hilsenbeck SG, Chamness GC, Lewis MT, Dobrolecki LE, Jain D, Sahoo S, Osborne CK, Chang JC. DNA repair signature is associated with anthracycline response in triple negative breast cancer patients. Breast Cancer Research and Treatment. 123: 189-96. PMID 20582464 DOI: 10.1007/S10549-010-0983-Z |
0.401 |
|
| 2010 |
Dave B, Lewis MT, Chang JC. Abstract 4213: Lentiviral shRNA screen testing a gene signature of breast cancer stem cells using high throughput mammosphere assays Cancer Research. 70: 4213-4213. DOI: 10.1158/1538-7445.Am10-4213 |
0.406 |
|
| 2010 |
Chang J, Dave B. Gene Expression Profiles Differentiating Between Breast Cancers Clinically Responsive or Resistant to Letrozole Breast Diseases: a Year Book Quarterly. 21: 50-51. DOI: 10.1016/S1043-321X(10)79484-4 |
0.391 |
|
| 2009 |
Escofet X, Twine C, Roberts A, Dave B, Rawlinson C, Chan D, Crosby T, Robinson M, Lewis W. Prognostic significance of endoluminal ultrasound defined tumor volume (EDTV) in patients diagnosed with esophageal cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e15519. PMID 27962290 DOI: 10.1200/Jco.2009.27.15_Suppl.E15519 |
0.318 |
|
| 2009 |
Crabtree JS, Jelinsky SA, Harris HA, Choe SE, Cotreau MM, Kimberland ML, Wilson E, Saraf KA, Liu W, McCampbell AS, Dave B, Broaddus RR, Brown EL, Kao W, Skotnicki JS, et al. Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway. Cancer Research. 69: 6171-8. PMID 19622772 DOI: 10.1158/0008-5472.Can-08-4471 |
0.303 |
|
| 2009 |
Dave B, Chang J. Treatment resistance in stem cells and breast cancer. Journal of Mammary Gland Biology and Neoplasia. 14: 79-82. PMID 19259795 DOI: 10.1007/S10911-009-9117-9 |
0.435 |
|
| 2009 |
Jennings TA, Mackintosh SG, Harrison MK, Sikora D, Sikora B, Dave B, Tackett AJ, Cameron CE, Raney KD. NS3 helicase from the hepatitis C virus can function as a monomer or oligomer depending on enzyme and substrate concentrations. The Journal of Biological Chemistry. 284: 4806-14. PMID 19088075 DOI: 10.1074/Jbc.M805540200 |
0.646 |
|
| 2009 |
Garrett J, Olivares M, Rinehart C, Dave B, Cook R, Chang J, Arteaga C. Transcriptional and Post-Translational Upregulation of HER3 (ErbB3) Counteracts Antitumor Effect of HER2 Tyrosine Kinase Inhibitors. Cancer Research. 69: 63-63. DOI: 10.1158/0008-5472.Sabcs-09-63 |
0.434 |
|
| 2009 |
Dave B, Lewis M, Chang J. Lentiviral shRNA Screen To Test the Validity of a Gene Signature of Breast Cancer Stem Cells Using High Throughput Mammosphere Assays. Cancer Research. 69: 1158-1158. DOI: 10.1158/0008-5472.Sabcs-09-1158 |
0.398 |
|
| 2009 |
Dave B, Tweardy D, Lewis M, Chang J. Inhibition of Breast Cancer Stem Cells (CSCs) by Novel STAT3 Inhibitors. Cancer Research. 69: 1155-1155. DOI: 10.1158/0008-5472.Sabcs-09-1155 |
0.469 |
|
| 2009 |
Rodriguez A, Rimawi M, Wu M, Dave B, Wong H, Landis M, Cairo M, Pavlick A, Froehlich A, Chamness G, Hilsenbeck S, Lewis M, Osborne C, Chang J. A BRCA1-Like, 25-Gene Assay Predicts for Anthracycline-Chemosensitivity in Sporadic Triple-Negative Breast Cancer. Cancer Research. 69: 110-110. DOI: 10.1158/0008-5472.Sabcs-09-110 |
0.384 |
|
| 2008 |
Lu KH, Wu W, Dave B, Slomovitz BM, Burke TW, Munsell MF, Broaddus RR, Walker CL. Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 2543-50. PMID 18451215 DOI: 10.1158/1078-0432.Ccr-07-0321 |
0.319 |
|
| 2005 |
Dave B, Eason RR, Till SR, Geng Y, Velarde MC, Badger TM, Simmen RC. The soy isoflavone genistein promotes apoptosis in mammary epithelial cells by inducing the tumor suppressor PTEN. Carcinogenesis. 26: 1793-803. PMID 15905199 DOI: 10.1093/Carcin/Bgi131 |
0.332 |
|
| 2002 |
Piccininni S, Varaklioti A, Nardelli M, Dave B, Raney KD, McCarthy JE. Modulation of the hepatitis C virus RNA-dependent RNA polymerase activity by the non-structural (NS) 3 helicase and the NS4B membrane protein. The Journal of Biological Chemistry. 277: 45670-9. PMID 12235135 DOI: 10.1074/Jbc.M204124200 |
0.54 |
|
| 2002 |
Mehta KD, Radominska-Pandya A, Kapoor GS, Dave B, Atkins BA. Critical role of diacylglycerol- and phospholipid-regulated protein kinase C epsilon in induction of low-density lipoprotein receptor transcription in response to depletion of cholesterol. Molecular and Cellular Biology. 22: 3783-93. PMID 11997513 DOI: 10.1128/Mcb.22.11.3783-3793.2002 |
0.305 |
|
| Show low-probability matches. |